文献速递免疫规划传染病防控与疫情报告

2018/2019年西西里岛流感疫苗对实验室确诊A(H1N1)pdm09和A(H3N2)中期效果估计

A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy).
PubMed 文献 · Vaccine · 2019-08-16

该研究采用检测阴性设计评估2018-2019流感季西西里岛季节性流感疫苗对A(H1N1)pdm09和A(H3N2)的中期效果。西西里岛流感感染几乎均为甲型,其中62.3%为A(H3N2)、36.3%为A(H1N1)pdm09。接种疫苗人群实验室确诊流感病例减少,对所有甲型流感总体调整疫苗效果为44.0%(95%CI: 11.2-64.7%)。

要点

  • 所有甲型流感总体调整疫苗效果为44.0%(95%CI: 11.2-64.7%)
  • 15-64岁组调整疫苗效果为59.5%(95%CI: 0.03-83.1)
  • 老年人调整疫苗效果为73.6%(95%CI: 29.4-90.2)

核心结论

  • 接种疫苗人群实验室确诊流感病例减少,对所有甲型流感总体呈现显著保护值。

研究设计与样本

  • 采用检测阴性设计评估2018-2019流感季西西里岛季节性流感疫苗效果。

主要发现

  • 西西里岛流感感染几乎均为甲型,其中62.3%为A(H3N2)、36.3%为A(H1N1)pdm09。
  • 所有甲型流感总体调整疫苗效果为44.0%(95%CI: 11.2-64.7%)。
  • 15-64岁年龄组调整疫苗效果为59.5%(95%CI: 0.03-83.1)。
  • 老年人调整疫苗效果为73.6%(95%CI: 29.4-90.2)。

关键数值与推荐

  • 所有甲型流感Adj-VE=44.0%(95%CI: 11.2-64.7%)。
  • 15-64岁组Adj-VE=59.5%(95%CI: 0.03-83.1)。
  • 老年人Adj-VE=73.6%(95%CI: 29.4-90.2)。

临床怎么用

  • 本中期估计支持在流感季推进疫苗接种以预防实验室确诊甲型流感。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Influenza season started in Italy during the month of October 2018, approaching the epidemic peak in January 2019. This report aim to explore the mid-term virologic surveillance data of the 2018-2019 influenza season in Sicily and to estimate the effectiveness of seasonal influenza vaccine (VE) against A(H1N1)pdm09 and A(H3N2) influenza viruses. A test-negative design was used to evaluate influenza VE. In Sicily, almost all influenza infections were sustained by influenza type A viruses, of which 62.3% were A(H3N2) and 36.3% A(H1N1)pdm09. A reduction of laboratory confirmed influenza cases in Sicilian population immunized against influenza were observed. In particular, an overall significant protective values were observed for any influenza A viruses (Adj-VE = 44.0%; 95%CI: 11.2-64.7%), especially among 15-64 years old age group (Adj-VE = 59.5%; 95%CI: 0.03-83.1) and among the elderly (Adj-VE = 73.6%; 95% CI: 29.4-90.2).

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Costantino C, Restivo V, Amodio E, et al. A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy). Vaccine. 2019. PMID: 31427134. doi:10.1016/j.vaccine.2019.08.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。